SilverBacteriV1, Main, Exploration, bibRecord, 000099

Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.

Identifieur interne : 000099 ( Main/Exploration ); précédent : 000098; suivant : 000100

Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.

Auteurs : Nathalie Karaky [Royaume-Uni] ; Andrew Kirby [Royaume-Uni] ; Andrew J. Mcbain [Royaume-Uni] ; Jonathan A. Butler [Royaume-Uni] ; Mohamed El Mohtadi [Royaume-Uni] ; Craig E. Banks [Royaume-Uni] ; Kathryn A. Whitehead [Royaume-Uni]

Source :

Archives of microbiology [ 1432-072X ] ; 2020.

RBID : pubmed:31915886

Descripteurs français

KwdFr :
- Antibactériens (pharmacologie), Argent (pharmacologie), Biofilms (croissance et développement), Brûlures (microbiologie), Brûlures (traitement médicamenteux), Graphite (pharmacologie), Humains (MeSH), Infections à Pseudomonas (microbiologie), Infections à Pseudomonas (traitement médicamenteux), Métaux lourds (pharmacologie), Plancton (effets des médicaments et des substances chimiques), Pseudomonas aeruginosa (effets des médicaments et des substances chimiques), Tests de sensibilité microbienne (MeSH).
MESH :
- croissance et développement : Biofilms.
- effets des médicaments et des substances chimiques : Plancton, Pseudomonas aeruginosa.
- microbiologie : Brûlures, Infections à Pseudomonas.
- pharmacologie : Antibactériens, Argent, Graphite, Métaux lourds.
- traitement médicamenteux : Brûlures, Infections à Pseudomonas.
- Humains, Tests de sensibilité microbienne.

English descriptors

KwdEn :
- Anti-Bacterial Agents (pharmacology), Biofilms (growth & development), Burns (drug therapy), Burns (microbiology), Graphite (pharmacology), Humans (MeSH), Metals, Heavy (pharmacology), Microbial Sensitivity Tests (MeSH), Plankton (drug effects), Pseudomonas Infections (drug therapy), Pseudomonas Infections (microbiology), Pseudomonas aeruginosa (drug effects), Silver (pharmacology).
MESH :
- chemical , pharmacology : Anti-Bacterial Agents, Graphite, Metals, Heavy, Silver.
- drug effects : Plankton, Pseudomonas aeruginosa.
- drug therapy : Burns, Pseudomonas Infections.
- growth & development : Biofilms.
- microbiology : Burns, Pseudomonas Infections.
- Humans, Microbial Sensitivity Tests.

Abstract

Burn infections caused by Pseudomonas aeruginosa pose a major complication in wound healing. This study aimed to determine the antimicrobial effect of metal ions, graphene (Gr), and graphene oxide (GO), individually and in combination, against the planktonic and biofilm states of two antimicrobially resistant clinical strains of P. aeruginosa each with different antibiotic resistance profiles. Minimum inhibitory, minimum bactericidal, and fractional inhibitory concentrations were performed to determine the efficacy of the metal ions and graphene composites individually and their synergy in combination. Crystal violet biofilm and XTT assays measured the biofilm inhibition and metabolic activity, respectively. Molybdenum, platinum, tin, gold, and palladium ions exhibited the greatest antimicrobial activity (MIC = 7.8-26.0 mg/L), whilst GO and Gr demonstrated moderate-to-no effect against the planktonic bacterial cells, irrespective of their antibiograms. Biofilms were inhibited by zinc, palladium, silver, and graphene. In combination, silver-graphene and molybdenum-graphene inhibited both the planktonic and biofilm forms of the bacteria making them potential candidates for development into topical antimicrobials for burns patients infected with antibiotic-resistant P. aeruginosa.

DOI: 10.1007/s00203-019-01803-z
PubMed: 31915886
PubMed Central: PMC7223729

Affiliations:

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000180
to stream Main, to step Curation: 000180

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.</title>
<author><name sortKey="Karaky, Nathalie" sort="Karaky, Nathalie" uniqKey="Karaky N" first="Nathalie" last="Karaky">Nathalie Karaky</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kirby, Andrew" sort="Kirby, Andrew" uniqKey="Kirby A" first="Andrew" last="Kirby">Andrew Kirby</name>
<affiliation wicri:level="4"><nlm:affiliation>Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName><settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcbain, Andrew J" sort="Mcbain, Andrew J" uniqKey="Mcbain A" first="Andrew J" last="Mcbain">Andrew J. Mcbain</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PT</wicri:regionArea>
<orgName type="university">Université de Manchester</orgName>
<placeName><settlement type="city">Manchester</settlement>
<region type="nation">Angleterre</region>
<region nuts="2" type="region">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Butler, Jonathan A" sort="Butler, Jonathan A" uniqKey="Butler J" first="Jonathan A" last="Butler">Jonathan A. Butler</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="El Mohtadi, Mohamed" sort="El Mohtadi, Mohamed" uniqKey="El Mohtadi M" first="Mohamed" last="El Mohtadi">Mohamed El Mohtadi</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Banks, Craig E" sort="Banks, Craig E" uniqKey="Banks C" first="Craig E" last="Banks">Craig E. Banks</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Science and Engineering, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Science and Engineering, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Whitehead, Kathryn A" sort="Whitehead, Kathryn A" uniqKey="Whitehead K" first="Kathryn A" last="Whitehead">Kathryn A. Whitehead</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK. k.a.whitehead@mmu.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:31915886</idno>
<idno type="pmid">31915886</idno>
<idno type="doi">10.1007/s00203-019-01803-z</idno>
<idno type="pmc">PMC7223729</idno>
<idno type="wicri:Area/Main/Corpus">000180</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000180</idno>
<idno type="wicri:Area/Main/Curation">000180</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000180</idno>
<idno type="wicri:Area/Main/Exploration">000180</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.</title>
<author><name sortKey="Karaky, Nathalie" sort="Karaky, Nathalie" uniqKey="Karaky N" first="Nathalie" last="Karaky">Nathalie Karaky</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Kirby, Andrew" sort="Kirby, Andrew" uniqKey="Kirby A" first="Andrew" last="Kirby">Andrew Kirby</name>
<affiliation wicri:level="4"><nlm:affiliation>Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT</wicri:regionArea>
<orgName type="university">Université de Leeds</orgName>
<placeName><settlement type="city">Leeds</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Yorkshire-et-Humber</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Mcbain, Andrew J" sort="Mcbain, Andrew J" uniqKey="Mcbain A" first="Andrew J" last="Mcbain">Andrew J. Mcbain</name>
<affiliation wicri:level="4"><nlm:affiliation>Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PT</wicri:regionArea>
<orgName type="university">Université de Manchester</orgName>
<placeName><settlement type="city">Manchester</settlement>
<region type="nation">Angleterre</region>
<region nuts="2" type="region">Grand Manchester</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Butler, Jonathan A" sort="Butler, Jonathan A" uniqKey="Butler J" first="Jonathan A" last="Butler">Jonathan A. Butler</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="El Mohtadi, Mohamed" sort="El Mohtadi, Mohamed" uniqKey="El Mohtadi M" first="Mohamed" last="El Mohtadi">Mohamed El Mohtadi</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Banks, Craig E" sort="Banks, Craig E" uniqKey="Banks C" first="Craig E" last="Banks">Craig E. Banks</name>
<affiliation wicri:level="1"><nlm:affiliation>Faculty of Science and Engineering, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Faculty of Science and Engineering, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Whitehead, Kathryn A" sort="Whitehead, Kathryn A" uniqKey="Whitehead K" first="Kathryn A" last="Whitehead">Kathryn A. Whitehead</name>
<affiliation wicri:level="1"><nlm:affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK. k.a.whitehead@mmu.ac.uk.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD</wicri:regionArea>
<wicri:noRegion>M1 5GD</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Archives of microbiology</title>
<idno type="eISSN">1432-072X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Anti-Bacterial Agents (pharmacology)</term>
<term>Biofilms (growth & development)</term>
<term>Burns (drug therapy)</term>
<term>Burns (microbiology)</term>
<term>Graphite (pharmacology)</term>
<term>Humans (MeSH)</term>
<term>Metals, Heavy (pharmacology)</term>
<term>Microbial Sensitivity Tests (MeSH)</term>
<term>Plankton (drug effects)</term>
<term>Pseudomonas Infections (drug therapy)</term>
<term>Pseudomonas Infections (microbiology)</term>
<term>Pseudomonas aeruginosa (drug effects)</term>
<term>Silver (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Antibactériens (pharmacologie)</term>
<term>Argent (pharmacologie)</term>
<term>Biofilms (croissance et développement)</term>
<term>Brûlures (microbiologie)</term>
<term>Brûlures (traitement médicamenteux)</term>
<term>Graphite (pharmacologie)</term>
<term>Humains (MeSH)</term>
<term>Infections à Pseudomonas (microbiologie)</term>
<term>Infections à Pseudomonas (traitement médicamenteux)</term>
<term>Métaux lourds (pharmacologie)</term>
<term>Plancton (effets des médicaments et des substances chimiques)</term>
<term>Pseudomonas aeruginosa (effets des médicaments et des substances chimiques)</term>
<term>Tests de sensibilité microbienne (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Bacterial Agents</term>
<term>Graphite</term>
<term>Metals, Heavy</term>
<term>Silver</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr"><term>Biofilms</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Plankton</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Burns</term>
<term>Pseudomonas Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Plancton</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en"><term>Biofilms</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr"><term>Brûlures</term>
<term>Infections à Pseudomonas</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en"><term>Burns</term>
<term>Pseudomonas Infections</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antibactériens</term>
<term>Argent</term>
<term>Graphite</term>
<term>Métaux lourds</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Brûlures</term>
<term>Infections à Pseudomonas</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Microbial Sensitivity Tests</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Tests de sensibilité microbienne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Burn infections caused by Pseudomonas aeruginosa pose a major complication in wound healing. This study aimed to determine the antimicrobial effect of metal ions, graphene (Gr), and graphene oxide (GO), individually and in combination, against the planktonic and biofilm states of two antimicrobially resistant clinical strains of P. aeruginosa each with different antibiotic resistance profiles. Minimum inhibitory, minimum bactericidal, and fractional inhibitory concentrations were performed to determine the efficacy of the metal ions and graphene composites individually and their synergy in combination. Crystal violet biofilm and XTT assays measured the biofilm inhibition and metabolic activity, respectively. Molybdenum, platinum, tin, gold, and palladium ions exhibited the greatest antimicrobial activity (MIC = 7.8-26.0 mg/L), whilst GO and Gr demonstrated moderate-to-no effect against the planktonic bacterial cells, irrespective of their antibiograms. Biofilms were inhibited by zinc, palladium, silver, and graphene. In combination, silver-graphene and molybdenum-graphene inhibited both the planktonic and biofilm forms of the bacteria making them potential candidates for development into topical antimicrobials for burns patients infected with antibiotic-resistant P. aeruginosa.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM"><PMID Version="1">31915886</PMID>
<DateCompleted><Year>2020</Year>
<Month>07</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>09</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-072X</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>202</Volume>
<Issue>5</Issue>
<PubDate><Year>2020</Year>
<Month>Jul</Month>
</PubDate>
</JournalIssue>
<Title>Archives of microbiology</Title>
<ISOAbbreviation>Arch Microbiol</ISOAbbreviation>
</Journal>
<ArticleTitle>Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.</ArticleTitle>
<Pagination><MedlinePgn>995-1004</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1007/s00203-019-01803-z</ELocationID>
<Abstract><AbstractText>Burn infections caused by Pseudomonas aeruginosa pose a major complication in wound healing. This study aimed to determine the antimicrobial effect of metal ions, graphene (Gr), and graphene oxide (GO), individually and in combination, against the planktonic and biofilm states of two antimicrobially resistant clinical strains of P. aeruginosa each with different antibiotic resistance profiles. Minimum inhibitory, minimum bactericidal, and fractional inhibitory concentrations were performed to determine the efficacy of the metal ions and graphene composites individually and their synergy in combination. Crystal violet biofilm and XTT assays measured the biofilm inhibition and metabolic activity, respectively. Molybdenum, platinum, tin, gold, and palladium ions exhibited the greatest antimicrobial activity (MIC = 7.8-26.0 mg/L), whilst GO and Gr demonstrated moderate-to-no effect against the planktonic bacterial cells, irrespective of their antibiograms. Biofilms were inhibited by zinc, palladium, silver, and graphene. In combination, silver-graphene and molybdenum-graphene inhibited both the planktonic and biofilm forms of the bacteria making them potential candidates for development into topical antimicrobials for burns patients infected with antibiotic-resistant P. aeruginosa.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Karaky</LastName>
<ForeName>Nathalie</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Kirby</LastName>
<ForeName>Andrew</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Leeds Institute of Medical Research, University of Leeds, Leeds, LS2 9JT, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McBain</LastName>
<ForeName>Andrew J</ForeName>
<Initials>AJ</Initials>
<AffiliationInfo><Affiliation>Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, The University of Manchester, Oxford Road, Manchester, M13 9PT, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Butler</LastName>
<ForeName>Jonathan A</ForeName>
<Initials>JA</Initials>
<AffiliationInfo><Affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>El Mohtadi</LastName>
<ForeName>Mohamed</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Banks</LastName>
<ForeName>Craig E</ForeName>
<Initials>CE</Initials>
<AffiliationInfo><Affiliation>Faculty of Science and Engineering, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Whitehead</LastName>
<ForeName>Kathryn A</ForeName>
<Initials>KA</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0001-6001-6686</Identifier>
<AffiliationInfo><Affiliation>Microbiology at Interfaces, Manchester Metropolitan University, Chester Street, Manchester, M1 5GD, UK. k.a.whitehead@mmu.ac.uk.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>VC Scholarship</GrantID>
<Agency>Manchester Metropolitan University</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>01</Month>
<Day>08</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Germany</Country>
<MedlineTA>Arch Microbiol</MedlineTA>
<NlmUniqueID>0410427</NlmUniqueID>
<ISSNLinking>0302-8933</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D019216">Metals, Heavy</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000628730">graphene oxide</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>3M4G523W1G</RegistryNumber>
<NameOfSubstance UI="D012834">Silver</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>7782-42-5</RegistryNumber>
<NameOfSubstance UI="D006108">Graphite</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018441" MajorTopicYN="N">Biofilms</DescriptorName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002056" MajorTopicYN="N">Burns</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006108" MajorTopicYN="N">Graphite</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D019216" MajorTopicYN="N">Metals, Heavy</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010933" MajorTopicYN="N">Plankton</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011552" MajorTopicYN="N">Pseudomonas Infections</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011550" MajorTopicYN="N">Pseudomonas aeruginosa</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012834" MajorTopicYN="N">Silver</DescriptorName>
<QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibiotic resistance</Keyword>
<Keyword MajorTopicYN="N">Burns</Keyword>
<Keyword MajorTopicYN="N">Graphene oxide</Keyword>
<Keyword MajorTopicYN="N">Metal ions</Keyword>
<Keyword MajorTopicYN="N">P. aeruginosa</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year>
<Month>11</Month>
<Day>22</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2019</Year>
<Month>12</Month>
<Day>21</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2019</Year>
<Month>12</Month>
<Day>17</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>1</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>1</Month>
<Day>10</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">31915886</ArticleId>
<ArticleId IdType="doi">10.1007/s00203-019-01803-z</ArticleId>
<ArticleId IdType="pii">10.1007/s00203-019-01803-z</ArticleId>
<ArticleId IdType="pmc">PMC7223729</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>J Chin Med Assoc. 2018 Jan;81(1):7-11</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29042186</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drugs Context. 2018 May 29;7:212527</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29872449</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Materials (Basel). 2017 Sep 11;10(9):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28892011</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Drug Deliv Rev. 2016 Oct 1;105(Pt B):176-189</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27129441</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Nanotechnol. 2013 Aug;8(8):594-601</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23832191</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Antimicrob Chemother. 2007 Apr;59(4):587-90</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17307768</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACS Nano. 2011 Oct 25;5(10):8100-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21932790</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Nanomedicine. 2014 Aug 08;9:3801-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25143729</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACS Nano. 2010 Jul 27;4(7):4317-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20593851</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Nanomedicine. 2012;7:5901-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23226696</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>ACS Nano. 2010 Oct 26;4(10):5731-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20925398</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2010 Jun;8(6):423-35</Citation>
<ArticleIdList><ArticleId IdType="pubmed">20440275</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mayo Clin Proc. 2012 Mar;87(3):290-308</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22386185</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Appl Environ Microbiol. 2007 Mar;73(6):1712-20</Citation>
<ArticleIdList><ArticleId IdType="pubmed">17261510</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>mSphere. 2016 Apr 27;1(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27303724</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Microbiol. 2013 Jun;11(6):371-84</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23669886</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Adv Pharm Bull. 2015 Mar;5(1):19-23</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25789215</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Microbiol Infect. 2012 Mar;18(3):268-81</Citation>
<ArticleIdList><ArticleId IdType="pubmed">21793988</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Curr Microbiol. 2016 Oct;73(4):474-82</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27324342</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Basic Clin Pharm. 2014 Dec;6(1):29-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25538469</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>S Afr J Surg. 2013 May 03;51(2):50-3</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23725892</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci Rep. 2017 Jul 19;7(1):5911</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28724953</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nanotoxicology. 2012 Dec;6:857-66</Citation>
<ArticleIdList><ArticleId IdType="pubmed">22007647</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Intensive Care. 2015 Dec;5(1):61</Citation>
<ArticleIdList><ArticleId IdType="pubmed">26261001</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Royaume-Uni</li>
</country>
<region><li>Angleterre</li>
<li>Grand Manchester</li>
<li>Yorkshire-et-Humber</li>
</region>
<settlement><li>Leeds</li>
<li>Manchester</li>
</settlement>
<orgName><li>Université de Leeds</li>
<li>Université de Manchester</li>
</orgName>
</list>
<tree><country name="Royaume-Uni"><noRegion><name sortKey="Karaky, Nathalie" sort="Karaky, Nathalie" uniqKey="Karaky N" first="Nathalie" last="Karaky">Nathalie Karaky</name>
</noRegion>
<name sortKey="Banks, Craig E" sort="Banks, Craig E" uniqKey="Banks C" first="Craig E" last="Banks">Craig E. Banks</name>
<name sortKey="Butler, Jonathan A" sort="Butler, Jonathan A" uniqKey="Butler J" first="Jonathan A" last="Butler">Jonathan A. Butler</name>
<name sortKey="El Mohtadi, Mohamed" sort="El Mohtadi, Mohamed" uniqKey="El Mohtadi M" first="Mohamed" last="El Mohtadi">Mohamed El Mohtadi</name>
<name sortKey="Kirby, Andrew" sort="Kirby, Andrew" uniqKey="Kirby A" first="Andrew" last="Kirby">Andrew Kirby</name>
<name sortKey="Mcbain, Andrew J" sort="Mcbain, Andrew J" uniqKey="Mcbain A" first="Andrew J" last="Mcbain">Andrew J. Mcbain</name>
<name sortKey="Whitehead, Kathryn A" sort="Whitehead, Kathryn A" uniqKey="Whitehead K" first="Kathryn A" last="Whitehead">Kathryn A. Whitehead</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Terre/explor/SilverBacteriV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000099 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000099 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Terre
   |area=    SilverBacteriV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:31915886
   |texte=   Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:31915886" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a SilverBacteriV1

This area was generated with Dilib version V0.6.38.
Data generation: Mon Feb 1 22:59:42 2021. Site generation: Mon Feb 1 23:01:29 2021

	Serveur d'exploration SilverBacteriV1
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SilverBacteriV1

Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.

Metal ions and graphene-based compounds as alternative treatment options for burn wounds infected by antibiotic-resistant Pseudomonas aeruginosa.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki